[1]
Passalacqua, M.I. et al. 2023. Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient. Acta Biomedica Atenei Parmensis. 94, S1 (Mar. 2023), e2023070. DOI:https://doi.org/10.23750/abm.v94iS1.14114.